Rockville, MD, United States of America

Thomas Maciag

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Rorer Biotechnology Inc.. Active years: 1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas Maciag. Retrieved from https://idiyas.com/inventor/thomas-maciag-yk4v15jj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Thomas Maciag

Introduction

Thomas Maciag is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of recombinant DNA technology. His work has implications for both diagnostic applications and potential treatments for damaged blood vessels.

Latest Patents

Maciag holds a patent for a recombinant DNA vector encoding human endothelial cell growth factor. This invention utilizes recombinant DNA technology to create cloning vehicles that encode the endothelial cell growth factor (ECGF) protein. The procedures outlined in his patent allow for the recovery of ECGF protein that is essentially free of other human-origin proteins. This product is particularly useful in various diagnostic applications and holds promise for treating damaged blood vessels and other endothelial cell-line structures. He has 1 patent to his name.

Career Highlights

Throughout his career, Maciag has worked with prominent organizations, including Rorer Biotechnology Inc. and the American National Red Cross. His experience in these institutions has allowed him to contribute to advancements in biotechnology and healthcare.

Collaborations

Maciag has collaborated with several professionals in his field, including Michael Jaye and Wilson Burgess. These collaborations have further enriched his work and expanded the impact of his inventions.

Conclusion

Thomas Maciag's contributions to biotechnology, particularly through his patent on endothelial cell growth factor, highlight his innovative spirit and dedication to improving medical treatments. His work continues to influence the field and offers hope for future advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…